Your browser doesn't support javascript.
loading
Partnering on vaccines to counter multi-drug resistant threats: Workshop proceedings, Biomedical Advanced Research and Development Authority.
Bergmann, Julie N; Killen-Cade, Rushyannah R; Parish, Lindsay A; Albrecht, Mark T; Wolfe, Daniel N.
Afiliação
  • Bergmann JN; Department of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Washington DC, USA.
  • Killen-Cade RR; Department of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Washington DC, USA.
  • Parish LA; Department of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Washington DC, USA.
  • Albrecht MT; Department of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Washington DC, USA.
  • Wolfe DN; Department of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Washington DC, USA.
Hum Vaccin Immunother ; 18(5): 2058840, 2022 11 30.
Article em En | MEDLINE | ID: mdl-35417305
ABSTRACT
On March 12, 2021, the Biomedical Advanced Research and Development Authority (BARDA) sponsored a virtual market research workshop, "Partnering on Vaccines to Counter Multi-Drug Resistant Threats," to discuss the threat of antimicrobial resistance in the context of BARDA's mission space and the challenges encountered during the development of vaccines for specific antimicrobial resistant bacteria. The workshop convened representatives with expertise in vaccine development from government, academia, and industry. This report summarizes the presentations and subsequent discussions from the workshop and highlights existing challenges to advance the development of vaccine candidates for antimicrobial resistant pathogens, including Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Antibacterianos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Antibacterianos Idioma: En Ano de publicação: 2022 Tipo de documento: Article